While immunophenotyping is highly informative, it has some limitations. The technique requires high-quality samples and precise handling to avoid false results. Additionally, it may not be able to detect minimal residual disease or very low levels of cancer cells. Interpretation of results also requires specialized expertise, as the expression of markers can vary significantly among different cancer subtypes and even among patients with the same type of cancer.
